Ganetespib selectively sensitizes cancer cells for proximal and distal spread-out Bragg peak proton irradiation.

Our findings illustrate a proton-specific sensitizing effect of low-dosed ganetespib in both employed cell lines and at both investigated SOBP positions. We provide additional experimental data on cellular response and a rational for future combinatorial approaches with proton radiotherapy.